发明名称 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
摘要 The invention relates to neuromodulatory oligomers of the amyloid-β(1-42) protein, a particular production method, by means of which the oligomer can be obtained in a reproducible manner at high yield, the use of the oligomers as diagnostic and therapeutics agents, for the generation of oligomer-specific antibodies and for the discovery of substances which can interact with the oligomers and in the formation thereof. Corresponding methods for the production of the antibodies and for discovery of the substances are also disclosed as are the antibodies themselves and the use of the antibodies or substances as diagnostic and therapeutic agents. The invention further relates to derivatives of the oligomers and oligomers based on abbreviated forms of the amyloid-β(1-42) proteins, the production and use thereof.
申请公布号 US9176150(B2) 申请公布日期 2015.11.03
申请号 US201113195533 申请日期 2011.08.01
申请人 AbbVie Deutschland GmbH & Co. KG 发明人 Hillen Heinz;Striebinger Andreas;Krantz Carsten;Moeller Achim;Mueller Reinhold
分类号 C07K16/18;G01N33/68;A61K38/17;C07K14/47;G01N33/53;A61K39/395 主分类号 C07K16/18
代理机构 Michael Best & Friedrich LLP 代理人 Mueller Lisa V.;Michael Best & Friedrich LLP
主权项 1. An isolated antibody which binds an N-terminal truncated amyloid-β (“Aβ”)(1-42) oligomer comprising an Aβ(X-42) fragment, wherein X is 10 to 24, the isolated antibody obtainable by a method comprising: a) immunizing a host with the N-terminal truncated Aβ(1-42) oligomer; and b) obtaining an antibody-containing host serum produced as a response to said immunization,wherein the isolated antibody binds the N-terminal truncated Aβ(1-42) oligomer with 10-fold greater affinity than an amyloid derived, diffusible and dementing ligand (ADDL),wherein the N-terminal truncated Aβ(1-42) oligomer is produced by a process comprising: i) exposing a monomeric Aβ(1-42) protein to a detergent to form an intermediate oligomer; ii) reducing the detergent action and further incubating the intermediate oligomer to form an Aβ(1-42) oligomer; and iii) treating the Aβ(1-42) oligomer with a protease to form the N-terminal truncated Aβ(1-42) oligomer,wherein the detergent is a compound of formula R—X, wherein the radical R is unbranched or branched alkyl having from 6 to 20 carbon atoms or unbranched or branched alkenyl having from 6 to 20 carbon atoms, and the radical X is an acidic group or salt thereof.
地址 Wiesbaden DE